Vandetanib and ADAM inhibitors synergistically attenuate the pathological migration of EBV-infected retinal pigment epithelial cells by regulating the VEGF-mediated MAPK pathway (Q37734665)
Jump to navigation
Jump to search
scientific article published on 08 February 2017
Language | Label | Description | Also known as |
---|---|---|---|
English | Vandetanib and ADAM inhibitors synergistically attenuate the pathological migration of EBV-infected retinal pigment epithelial cells by regulating the VEGF-mediated MAPK pathway |
scientific article published on 08 February 2017 |
Statements
1 reference
Vandetanib and ADAM inhibitors synergistically attenuate the pathological migration of EBV-infected retinal pigment epithelial cells by regulating the VEGF-mediated MAPK pathway (English)
1 reference
Daejin Kim
1 reference
Hyun-Suk Ko
1 reference
Ga Bin Park
1 reference
Dae Young Hur
1 reference
Yeong Seok Kim
1 reference
Jae Wook Yang
1 reference
8 February 2017
1 reference
1 reference
1415-1425
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference